GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Sale Of Business

Stella Diagnostics (Stella Diagnostics) Sale Of Business : $ Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Sale Of Business?

Stella Diagnostics's sale of business for the three months ended in Sep. 2023 was $0.00 Mil. It means Stella Diagnostics gained $0.00 Mil from selling business. Stella Diagnostics does not have enough years/quarters to calculate the sale of business for the trailing twelve months (TTM) ended in Sep. 2023.

Compared with last quarter ($0.00 Mil in Sep. 2022 ), Stella Diagnostics gained the same money from selling business in Sep. 2023 ($0.00 Mil).


Stella Diagnostics Sale Of Business Historical Data

The historical data trend for Stella Diagnostics's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Sale Of Business Chart

Stella Diagnostics Annual Data
Trend
Sale Of Business

Stella Diagnostics Quarterly Data
Sep22 Sep23
Sale Of Business - -

Stella Diagnostics Sale Of Business Calculation

The amount earned to sell business.



Stella Diagnostics Sale Of Business Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus